Moderna Operating Cash Flow increased by 25.6% to -$630.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.2%, from -$1.04B to -$630.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.06B | $3.28B | $3.31B | $2.76B | $304.00M | $252.00M | $1.66B | -$1.23B | -$915.00M | -$1.60B | -$989.00M | -$1.27B | -$1.57B | -$1.04B | -$919.00M | -$847.00M | -$630.00M |
| QoQ Change | — | -19.4% | +1.0% | -16.5% | -89.0% | -17.1% | +559.5% | -173.7% | +25.3% | -74.9% | +38.2% | -28.8% | -22.9% | +33.8% | +11.4% | +7.8% | +25.6% |
| YoY Change | — | — | — | — | -92.5% | -92.3% | -49.8% | -144.3% | -401.0% | -734.9% | +19.3% | -39.2% | +2.1% | -4.9% | +27.9% | +45.9% | +39.2% |